High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli
- 30 October 2003
- journal article
- Published by Elsevier in Protein Expression and Purification
- Vol. 33 (1) , 80-91
- https://doi.org/10.1016/j.pep.2003.09.009
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent VaccineJournal of Virology, 2001
- Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challengeVaccine, 2000
- A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeysVaccine, 2000
- Live attenuated tetravalent dengue vaccineVaccine, 2000
- A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in miceVaccine, 2000
- Perspectives for the Treatment of Infections with FlaviviridaeClinical Microbiology Reviews, 2000
- Evaluation of molecular strategies to develop a live dengue vaccineClinical and Diagnostic Virology, 1998
- Dengue and Dengue Hemorrhagic FeverClinical Microbiology Reviews, 1998
- Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus MonkeysThe Journal of Infectious Diseases, 1996
- Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in miceVaccine, 1994